GE HealthCare Technologies Inc. $GEHC Shares Sold by Arizona State Retirement System

Arizona State Retirement System decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 124,969 shares of the company’s stock after selling 9,911 shares during the period. Arizona State Retirement System’s holdings in GE HealthCare Technologies were worth $10,250,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Capital Research Global Investors grew its position in shares of GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after buying an additional 4,998,154 shares in the last quarter. Dodge & Cox grew its position in shares of GE HealthCare Technologies by 16.8% during the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after buying an additional 3,949,361 shares in the last quarter. Boston Partners acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $287,627,000. Temasek Holdings Private Ltd acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $99,922,000. Finally, Hotchkis & Wiley Capital Management LLC grew its position in shares of GE HealthCare Technologies by 17.1% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after buying an additional 1,232,828 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on GEHC shares. Barclays boosted their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Mizuho lowered their price objective on GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday, April 13th. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price objective for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, BTIG Research reiterated a “buy” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a report on Tuesday, April 21st. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $89.77.

GE HealthCare Technologies Trading Down 1.4%

NASDAQ:GEHC opened at $68.89 on Friday. The stock’s 50 day moving average price is $74.65 and its 200 day moving average price is $77.79. The company has a market capitalization of $31.43 billion, a PE ratio of 15.11, a P/E/G ratio of 1.54 and a beta of 1.17. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 52-week low of $66.95 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 5 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.